11.50

0.69% -0.08

After Hours: 11.46 -0.04 -0.35%

Elicio Therapeutics Inc (ELTX)

Overview News Price History Discussions Forecast

Elicio Therapeutics Inc stock is traded at $11.50, with a volume of 60,353. It is down -0.69% in the last 24 hours and up +22.34% over the past month. Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Previous Close:

$11.58

Open:

$11.52

24h Volume:

60,353

Relative Volume:

0.78

Market Cap:

$187.89M

Revenue:

Net Income/Loss:

$-33.82M

P/E Ratio:

-0.4494

EPS:

-25.5891

Net Cash Flow:

$-66.04M

1W Performance:

+0.17%

1M Performance:

+22.34%

6M Performance:

+44.65%

1Y Performance:

+182.56%

1-Day Range:

$11.20

$11.79

1-Week Range:

$11.14

$11.89

52-Week Range:

$4.05

$12.42

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name

Elicio Therapeutics Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(857) 209-0050

Address

451 D STREET, 5TH FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

ELTX's Discussions on Twitter

Compare ELTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELTX Elicio Therapeutics Inc	11.50	192.46M	0	-33.82M	-66.04M	-25.59
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Elicio Therapeutics Inc (ELTX)

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Compare ELTX with other stocks

Elicio Therapeutics Inc Stock (ELTX) Latest News

Elicio Therapeutics Inc. stock momentum explainedJuly 2025 Review & Expert Approved Momentum Ideas - Newser

Risk adjusted return profile for Elicio Therapeutics Inc. analyzedQuarterly Trade Review & High Win Rate Trade Tips - Newser

Can you recover from losses in Elicio Therapeutics Inc.Buy Signal & Momentum Based Trading Signals - Newser

Is Elicio Therapeutics Inc. stock entering bullish territory2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser

Building trade automation scripts for Elicio Therapeutics Inc.CPI Data & High Return Stock Watch Alerts - Newser

Does Elicio Therapeutics Inc. show high probability of reboundJuly 2025 Decliners & Weekly Market Pulse Updates - Newser

Multi asset correlation models including Elicio Therapeutics Inc.Risk Management & Weekly High Return Stock Opportunities - Newser

Is Elicio Therapeutics Inc. stock bottoming outJuly 2025 Opening Moves & Expert Curated Trade Setups - Newser

Will Elicio Therapeutics Inc. rebound enough to break evenWeekly Trade Analysis & Stock Portfolio Risk Management - Newser

Volume spikes in Elicio Therapeutics Inc. stock – what they mean2025 Pullback Review & Low Risk Growth Stock Ideas - Newser

Published on: 2025-09-12 13:20:15 - Newser

Key resistance and support levels for Elicio Therapeutics Inc.Chart Signals & Real-Time Chart Pattern Alerts - Newser

Is it too late to sell Elicio Therapeutics Inc.Earnings Recap Summary & Weekly Top Gainers Trade List - Newser

Is Elicio Therapeutics Inc. a candidate for recovery playQuarterly Portfolio Summary & Free Low Drawdown Momentum Trade Ideas - Newser

Does Elicio Therapeutics Inc. qualify in momentum factor screeningPortfolio Update Summary & Safe Capital Growth Tips - Newser

Real time pattern detection on Elicio Therapeutics Inc. stockJuly 2025 Technicals & Expert Curated Trade Setup Alerts - Newser

What Fibonacci levels say about Elicio Therapeutics Inc. rebound2025 Volatility Report & Consistent Growth Stock Picks - Newser

Full technical analysis of Elicio Therapeutics Inc. stock2025 Top Decliners & Safe Capital Growth Tips - Newser

Exit strategy if you’re trapped in Elicio Therapeutics Inc.Analyst Downgrade & Stock Portfolio Risk Control - Newser

Published on: 2025-09-11 20:02:53 - Newser

Why Elicio Therapeutics Inc. is moving todayMarket Sentiment Report & Technical Analysis for Trade Confirmation - Newser

Momentum divergence signals in Elicio Therapeutics Inc. chartInsider Selling & Expert-Curated Trade Recommendations - Newser

Tick level data insight on Elicio Therapeutics Inc. volatilityJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser

Candlestick signals on Elicio Therapeutics Inc. stock todayTrade Ideas & Detailed Earnings Play Alerts - Newser

Signal strength of Elicio Therapeutics Inc. stock in tech scannersMarket Activity Report & Fast Moving Trade Plans - Newser

What indicators show strength in Elicio Therapeutics Inc.2025 AllTime Highs & Safe Entry Point Alerts - Newser

Is Elicio Therapeutics Inc. stock reversal real or fakeWeekly Trading Summary & Weekly Stock Breakout Alerts - Newser

How to integrate Elicio Therapeutics Inc. into portfolio analysis toolsWeekly Loss Report & Reliable Price Breakout Alerts - Newser

News impact scoring models applied to Elicio Therapeutics Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - Newser

Can technical indicators confirm Elicio Therapeutics Inc.’s reversalWeekly Profit Recap & Consistent Growth Equity Picks - Newser

Elicio Therapeutics Inc. stock trend forecastPortfolio Performance Summary & Fast Moving Trade Plans - Newser

Elicio Therapeutics Inc Stock (ELTX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to ELTX